Growth hormone and metasomatotrophic diabetes: effects on insulin and proinsulin of serum and pancreas in dogs
β Scribed by J. Pierluissi; J. Campbell
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 561 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Endogenous and exogenous opiate-like compounds have been found to cause increased serum growth hormone and prolactin levels in animals, and, in some cases, humans. Naloxone, a relatively specific narcotic antagonist, decreases serum prolactin and growth hormone levels in animals. Naloxone (20 mg IV)
Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b